The Emerging Role of Ketamine in Acute Postoperative Pain Management
Purpose of Review Postoperative pain (POP) is among the most unpleasant experiences that patients face after surgery. Interest in and use of N-methyl-D-aspartate (NMDA) receptor antagonists for the management of POP has increased over the years with ketamine being the most popular drug of this class. Recent Findings Several randomized controlled trials found that the use of ketamine either alone or in combination with other medications leads to decreased postoperative pain and opioid consumption. However, there are other studies that have not found these benefits. The results as of now suggest that the role of intraoperative ketamine in postoperative pain control varies among different operative procedures. Summary While some studies have shown promise in ketamine’s potential use as a postoperative analgesic, there is still a great deal of proposed research and randomized controlled trials needed to deduce the most efficacious and tolerable form and dose of ketamine..
Medienart: |
Artikel |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
Zur Gesamtaufnahme - volume:27 |
---|---|
Enthalten in: |
Current pain and headache reports - 27(2023), 9 vom: 28. Juni, Seite 387-397 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Edinoff, Amber N. [VerfasserIn] |
---|
Links: |
Volltext [lizenzpflichtig] |
---|
Themen: |
---|
Anmerkungen: |
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. |
---|
doi: |
10.1007/s11916-023-01134-1 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
OLC2145268790 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | OLC2145268790 | ||
003 | DE-627 | ||
005 | 20240118103626.0 | ||
007 | tu | ||
008 | 240118s2023 xx ||||| 00| ||eng c | ||
024 | 7 | |a 10.1007/s11916-023-01134-1 |2 doi | |
035 | |a (DE-627)OLC2145268790 | ||
035 | |a (DE-He213)s11916-023-01134-1-p | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | 4 | |a 610 |q VZ |
100 | 1 | |a Edinoff, Amber N. |e verfasserin |0 (orcid)0000-0001-7436-6206 |4 aut | |
245 | 1 | 0 | |a The Emerging Role of Ketamine in Acute Postoperative Pain Management |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
338 | |a Band |b nc |2 rdacarrier | ||
500 | |a © The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. | ||
520 | |a Purpose of Review Postoperative pain (POP) is among the most unpleasant experiences that patients face after surgery. Interest in and use of N-methyl-D-aspartate (NMDA) receptor antagonists for the management of POP has increased over the years with ketamine being the most popular drug of this class. Recent Findings Several randomized controlled trials found that the use of ketamine either alone or in combination with other medications leads to decreased postoperative pain and opioid consumption. However, there are other studies that have not found these benefits. The results as of now suggest that the role of intraoperative ketamine in postoperative pain control varies among different operative procedures. Summary While some studies have shown promise in ketamine’s potential use as a postoperative analgesic, there is still a great deal of proposed research and randomized controlled trials needed to deduce the most efficacious and tolerable form and dose of ketamine. | ||
650 | 4 | |a Ketamine | |
650 | 4 | |a Opioids | |
650 | 4 | |a Pain | |
650 | 4 | |a Acute pain | |
650 | 4 | |a Postoperative pain | |
700 | 1 | |a Askins, Dorothy |4 aut | |
700 | 1 | |a Bobo, Elena |4 aut | |
700 | 1 | |a White, Kathryn L. |4 aut | |
700 | 1 | |a Eswani, Zahaan |4 aut | |
700 | 1 | |a Jackson, Eric D. |4 aut | |
700 | 1 | |a Wenger, Danielle M. |4 aut | |
700 | 1 | |a Kaye, Aaron J. |4 aut | |
700 | 1 | |a Cornett., Elyse M. |4 aut | |
700 | 1 | |a Kaye, Adam M. |4 aut | |
700 | 1 | |a Kaye, Alan D. |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Current pain and headache reports |d Springer US, 2001 |g 27(2023), 9 vom: 28. Juni, Seite 387-397 |w (DE-627)333033485 |w (DE-600)2055062-5 |w (DE-576)094530270 |x 1531-3433 |7 nnns |
773 | 1 | 8 | |g volume:27 |g year:2023 |g number:9 |g day:28 |g month:06 |g pages:387-397 |
856 | 4 | 1 | |u https://doi.org/10.1007/s11916-023-01134-1 |z lizenzpflichtig |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a SYSFLAG_A | ||
912 | |a GBV_OLC | ||
951 | |a AR | ||
952 | |d 27 |j 2023 |e 9 |b 28 |c 06 |h 387-397 |